Global Covid-19 Rapid Antigen Market Research Report 2026(Status and Outlook)
The global Covid-19 Rapid Antigen market size was estimated at USD 800.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of -5.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Covid-19 Rapid Antigen market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Covid-19 Rapid Antigen market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Covid-19 Rapid Antigen market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Covid-19 Rapid Antigen Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Covid-19 Rapid Antigen, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
This report offers a comprehensive and in-depth analysis of the global Covid-19 Rapid Antigen market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Covid-19 Rapid Antigen market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Covid-19 Rapid Antigen market.
Global Covid-19 Rapid Antigen Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Abbott
- Access Bio
- BD
- Quidel
- Fujirebio
- Ellume
- OraSure Technologies
- Clip Health
- Celltrion Healthcare
- Salofa Oy
- iHealth Labs
- Novegent
- Hangzhou Alltest Biotech
- Guangzhou Decheng Biotechnology
- SD Biosensor
- MP Biomedical
- Jiangsu Well Biotech
- CTK Biotech
- Hangzhou Laihe Biotech
- Innovation Scientific
- Biohit Healthcare
- ACON Biotech
- Assure Tech
- Hangzhou Clongene Biotech
- Hangzhou Testsea Biotechnology
Market Segmentation (by Type)
- Nasal Swab
- Oral Fluid/Saliva
Market Segmentation (by Application)
- Hospitals
- Scientific Research
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Covid-19 Rapid Antigen Market
Overview of the regional outlook of the Covid-19 Rapid Antigen Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Covid-19 Rapid Antigen Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Covid-19 Rapid Antigen, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Covid-19 Rapid Antigen
1.2 Key Market Segments
1.2.1 Covid-19 Rapid Antigen Segment by Type
1.2.2 Covid-19 Rapid Antigen Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COVID-19 RAPID ANTIGEN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Covid-19 Rapid Antigen Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Covid-19 Rapid Antigen Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COVID-19 RAPID ANTIGEN MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Covid-19 Rapid Antigen Product Life Cycle
3.3 Global Covid-19 Rapid Antigen Sales by Manufacturers (2020-2025)
3.4 Global Covid-19 Rapid Antigen Revenue Market Share by Manufacturers (2020-2025)
3.5 Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Covid-19 Rapid Antigen Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Covid-19 Rapid Antigen Market Competitive Situation and Trends
3.8.1 Covid-19 Rapid Antigen Market Concentration Rate
3.8.2 Global 5 and 10 Largest Covid-19 Rapid Antigen Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 COVID-19 RAPID ANTIGEN INDUSTRY CHAIN ANALYSIS
4.1 Covid-19 Rapid Antigen Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COVID-19 RAPID ANTIGEN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Covid-19 Rapid Antigen Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Covid-19 Rapid Antigen Market
5.7 ESG Ratings of Leading Companies
6 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Covid-19 Rapid Antigen Sales Market Share by Type (2020-2025)
6.3 Global Covid-19 Rapid Antigen Market Size by Type (2020-2025)
6.4 Global Covid-19 Rapid Antigen Price by Type (2020-2025)
7 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Covid-19 Rapid Antigen Market Sales by Application (2020-2025)
7.3 Global Covid-19 Rapid Antigen Market Size (M USD) by Application (2020-2025)
7.4 Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2020-2025)
8 COVID-19 RAPID ANTIGEN MARKET SALES BY REGION
8.1 Global Covid-19 Rapid Antigen Sales by Region
8.1.1 Global Covid-19 Rapid Antigen Sales by Region
8.1.2 Global Covid-19 Rapid Antigen Sales Market Share by Region
8.2 Global Covid-19 Rapid Antigen Market Size by Region
8.2.1 Global Covid-19 Rapid Antigen Market Size by Region
8.2.2 Global Covid-19 Rapid Antigen Market Size by Region
8.3 North America
8.3.1 North America Covid-19 Rapid Antigen Sales by Country
8.3.2 North America Covid-19 Rapid Antigen Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Covid-19 Rapid Antigen Sales by Country
8.4.2 Europe Covid-19 Rapid Antigen Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Covid-19 Rapid Antigen Sales by Region
8.5.2 Asia Pacific Covid-19 Rapid Antigen Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Covid-19 Rapid Antigen Sales by Country
8.6.2 South America Covid-19 Rapid Antigen Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Covid-19 Rapid Antigen Sales by Region
8.7.2 Middle East and Africa Covid-19 Rapid Antigen Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 COVID-19 RAPID ANTIGEN MARKET PRODUCTION BY REGION
9.1 Global Production of Covid-19 Rapid Antigen by Region(2020-2025)
9.2 Global Covid-19 Rapid Antigen Revenue Market Share by Region (2020-2025)
9.3 Global Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Covid-19 Rapid Antigen Production
9.4.1 North America Covid-19 Rapid Antigen Production Growth Rate (2020-2025)
9.4.2 North America Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Covid-19 Rapid Antigen Production
9.5.1 Europe Covid-19 Rapid Antigen Production Growth Rate (2020-2025)
9.5.2 Europe Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Covid-19 Rapid Antigen Production (2020-2025)
9.6.1 Japan Covid-19 Rapid Antigen Production Growth Rate (2020-2025)
9.6.2 Japan Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Covid-19 Rapid Antigen Production (2020-2025)
9.7.1 China Covid-19 Rapid Antigen Production Growth Rate (2020-2025)
9.7.2 China Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Covid-19 Rapid Antigen Product Overview
10.1.3 Abbott Covid-19 Rapid Antigen Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Access Bio
10.2.1 Access Bio Basic Information
10.2.2 Access Bio Covid-19 Rapid Antigen Product Overview
10.2.3 Access Bio Covid-19 Rapid Antigen Product Market Performance
10.2.4 Access Bio Business Overview
10.2.5 Access Bio SWOT Analysis
10.2.6 Access Bio Recent Developments
10.3 BD
10.3.1 BD Basic Information
10.3.2 BD Covid-19 Rapid Antigen Product Overview
10.3.3 BD Covid-19 Rapid Antigen Product Market Performance
10.3.4 BD Business Overview
10.3.5 BD SWOT Analysis
10.3.6 BD Recent Developments
10.4 Quidel
10.4.1 Quidel Basic Information
10.4.2 Quidel Covid-19 Rapid Antigen Product Overview
10.4.3 Quidel Covid-19 Rapid Antigen Product Market Performance
10.4.4 Quidel Business Overview
10.4.5 Quidel Recent Developments
10.5 Fujirebio
10.5.1 Fujirebio Basic Information
10.5.2 Fujirebio Covid-19 Rapid Antigen Product Overview
10.5.3 Fujirebio Covid-19 Rapid Antigen Product Market Performance
10.5.4 Fujirebio Business Overview
10.5.5 Fujirebio Recent Developments
10.6 Ellume
10.6.1 Ellume Basic Information
10.6.2 Ellume Covid-19 Rapid Antigen Product Overview
10.6.3 Ellume Covid-19 Rapid Antigen Product Market Performance
10.6.4 Ellume Business Overview
10.6.5 Ellume Recent Developments
10.7 OraSure Technologies
10.7.1 OraSure Technologies Basic Information
10.7.2 OraSure Technologies Covid-19 Rapid Antigen Product Overview
10.7.3 OraSure Technologies Covid-19 Rapid Antigen Product Market Performance
10.7.4 OraSure Technologies Business Overview
10.7.5 OraSure Technologies Recent Developments
10.8 Clip Health
10.8.1 Clip Health Basic Information
10.8.2 Clip Health Covid-19 Rapid Antigen Product Overview
10.8.3 Clip Health Covid-19 Rapid Antigen Product Market Performance
10.8.4 Clip Health Business Overview
10.8.5 Clip Health Recent Developments
10.9 Celltrion Healthcare
10.9.1 Celltrion Healthcare Basic Information
10.9.2 Celltrion Healthcare Covid-19 Rapid Antigen Product Overview
10.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Product Market Performance
10.9.4 Celltrion Healthcare Business Overview
10.9.5 Celltrion Healthcare Recent Developments
10.10 Salofa Oy
10.10.1 Salofa Oy Basic Information
10.10.2 Salofa Oy Covid-19 Rapid Antigen Product Overview
10.10.3 Salofa Oy Covid-19 Rapid Antigen Product Market Performance
10.10.4 Salofa Oy Business Overview
10.10.5 Salofa Oy Recent Developments
10.11 iHealth Labs
10.11.1 iHealth Labs Basic Information
10.11.2 iHealth Labs Covid-19 Rapid Antigen Product Overview
10.11.3 iHealth Labs Covid-19 Rapid Antigen Product Market Performance
10.11.4 iHealth Labs Business Overview
10.11.5 iHealth Labs Recent Developments
10.12 Novegent
10.12.1 Novegent Basic Information
10.12.2 Novegent Covid-19 Rapid Antigen Product Overview
10.12.3 Novegent Covid-19 Rapid Antigen Product Market Performance
10.12.4 Novegent Business Overview
10.12.5 Novegent Recent Developments
10.13 Hangzhou Alltest Biotech
10.13.1 Hangzhou Alltest Biotech Basic Information
10.13.2 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Overview
10.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Market Performance
10.13.4 Hangzhou Alltest Biotech Business Overview
10.13.5 Hangzhou Alltest Biotech Recent Developments
10.14 Guangzhou Decheng Biotechnology
10.14.1 Guangzhou Decheng Biotechnology Basic Information
10.14.2 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Overview
10.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Market Performance
10.14.4 Guangzhou Decheng Biotechnology Business Overview
10.14.5 Guangzhou Decheng Biotechnology Recent Developments
10.15 SD Biosensor
10.15.1 SD Biosensor Basic Information
10.15.2 SD Biosensor Covid-19 Rapid Antigen Product Overview
10.15.3 SD Biosensor Covid-19 Rapid Antigen Product Market Performance
10.15.4 SD Biosensor Business Overview
10.15.5 SD Biosensor Recent Developments
10.16 MP Biomedical
10.16.1 MP Biomedical Basic Information
10.16.2 MP Biomedical Covid-19 Rapid Antigen Product Overview
10.16.3 MP Biomedical Covid-19 Rapid Antigen Product Market Performance
10.16.4 MP Biomedical Business Overview
10.16.5 MP Biomedical Recent Developments
10.17 Jiangsu Well Biotech
10.17.1 Jiangsu Well Biotech Basic Information
10.17.2 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Overview
10.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Market Performance
10.17.4 Jiangsu Well Biotech Business Overview
10.17.5 Jiangsu Well Biotech Recent Developments
10.18 CTK Biotech
10.18.1 CTK Biotech Basic Information
10.18.2 CTK Biotech Covid-19 Rapid Antigen Product Overview
10.18.3 CTK Biotech Covid-19 Rapid Antigen Product Market Performance
10.18.4 CTK Biotech Business Overview
10.18.5 CTK Biotech Recent Developments
10.19 Hangzhou Laihe Biotech
10.19.1 Hangzhou Laihe Biotech Basic Information
10.19.2 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Overview
10.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Market Performance
10.19.4 Hangzhou Laihe Biotech Business Overview
10.19.5 Hangzhou Laihe Biotech Recent Developments
10.20 Innovation Scientific
10.20.1 Innovation Scientific Basic Information
10.20.2 Innovation Scientific Covid-19 Rapid Antigen Product Overview
10.20.3 Innovation Scientific Covid-19 Rapid Antigen Product Market Performance
10.20.4 Innovation Scientific Business Overview
10.20.5 Innovation Scientific Recent Developments
10.21 Biohit Healthcare
10.21.1 Biohit Healthcare Basic Information
10.21.2 Biohit Healthcare Covid-19 Rapid Antigen Product Overview
10.21.3 Biohit Healthcare Covid-19 Rapid Antigen Product Market Performance
10.21.4 Biohit Healthcare Business Overview
10.21.5 Biohit Healthcare Recent Developments
10.22 ACON Biotech
10.22.1 ACON Biotech Basic Information
10.22.2 ACON Biotech Covid-19 Rapid Antigen Product Overview
10.22.3 ACON Biotech Covid-19 Rapid Antigen Product Market Performance
10.22.4 ACON Biotech Business Overview
10.22.5 ACON Biotech Recent Developments
10.23 Assure Tech
10.23.1 Assure Tech Basic Information
10.23.2 Assure Tech Covid-19 Rapid Antigen Product Overview
10.23.3 Assure Tech Covid-19 Rapid Antigen Product Market Performance
10.23.4 Assure Tech Business Overview
10.23.5 Assure Tech Recent Developments
10.24 Hangzhou Clongene Biotech
10.24.1 Hangzhou Clongene Biotech Basic Information
10.24.2 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Overview
10.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Market Performance
10.24.4 Hangzhou Clongene Biotech Business Overview
10.24.5 Hangzhou Clongene Biotech Recent Developments
10.25 Hangzhou Testsea Biotechnology
10.25.1 Hangzhou Testsea Biotechnology Basic Information
10.25.2 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Overview
10.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Market Performance
10.25.4 Hangzhou Testsea Biotechnology Business Overview
10.25.5 Hangzhou Testsea Biotechnology Recent Developments
11 COVID-19 RAPID ANTIGEN MARKET FORECAST BY REGION
11.1 Global Covid-19 Rapid Antigen Market Size Forecast
11.2 Global Covid-19 Rapid Antigen Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Covid-19 Rapid Antigen Market Size Forecast by Country
11.2.3 Asia Pacific Covid-19 Rapid Antigen Market Size Forecast by Region
11.2.4 South America Covid-19 Rapid Antigen Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Covid-19 Rapid Antigen by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Covid-19 Rapid Antigen Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Covid-19 Rapid Antigen by Type (2026-2035)
12.1.2 Global Covid-19 Rapid Antigen Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Covid-19 Rapid Antigen by Type (2026-2035)
12.2 Global Covid-19 Rapid Antigen Market Forecast by Application (2026-2035)
12.2.1 Global Covid-19 Rapid Antigen Sales (K Units) Forecast by Application
12.2.2 Global Covid-19 Rapid Antigen Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Covid-19 Rapid Antigen
1.2 Key Market Segments
1.2.1 Covid-19 Rapid Antigen Segment by Type
1.2.2 Covid-19 Rapid Antigen Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COVID-19 RAPID ANTIGEN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Covid-19 Rapid Antigen Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Covid-19 Rapid Antigen Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COVID-19 RAPID ANTIGEN MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Covid-19 Rapid Antigen Product Life Cycle
3.3 Global Covid-19 Rapid Antigen Sales by Manufacturers (2020-2025)
3.4 Global Covid-19 Rapid Antigen Revenue Market Share by Manufacturers (2020-2025)
3.5 Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Covid-19 Rapid Antigen Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Covid-19 Rapid Antigen Market Competitive Situation and Trends
3.8.1 Covid-19 Rapid Antigen Market Concentration Rate
3.8.2 Global 5 and 10 Largest Covid-19 Rapid Antigen Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 COVID-19 RAPID ANTIGEN INDUSTRY CHAIN ANALYSIS
4.1 Covid-19 Rapid Antigen Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COVID-19 RAPID ANTIGEN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Covid-19 Rapid Antigen Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Covid-19 Rapid Antigen Market
5.7 ESG Ratings of Leading Companies
6 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Covid-19 Rapid Antigen Sales Market Share by Type (2020-2025)
6.3 Global Covid-19 Rapid Antigen Market Size by Type (2020-2025)
6.4 Global Covid-19 Rapid Antigen Price by Type (2020-2025)
7 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Covid-19 Rapid Antigen Market Sales by Application (2020-2025)
7.3 Global Covid-19 Rapid Antigen Market Size (M USD) by Application (2020-2025)
7.4 Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2020-2025)
8 COVID-19 RAPID ANTIGEN MARKET SALES BY REGION
8.1 Global Covid-19 Rapid Antigen Sales by Region
8.1.1 Global Covid-19 Rapid Antigen Sales by Region
8.1.2 Global Covid-19 Rapid Antigen Sales Market Share by Region
8.2 Global Covid-19 Rapid Antigen Market Size by Region
8.2.1 Global Covid-19 Rapid Antigen Market Size by Region
8.2.2 Global Covid-19 Rapid Antigen Market Size by Region
8.3 North America
8.3.1 North America Covid-19 Rapid Antigen Sales by Country
8.3.2 North America Covid-19 Rapid Antigen Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Covid-19 Rapid Antigen Sales by Country
8.4.2 Europe Covid-19 Rapid Antigen Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Covid-19 Rapid Antigen Sales by Region
8.5.2 Asia Pacific Covid-19 Rapid Antigen Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Covid-19 Rapid Antigen Sales by Country
8.6.2 South America Covid-19 Rapid Antigen Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Covid-19 Rapid Antigen Sales by Region
8.7.2 Middle East and Africa Covid-19 Rapid Antigen Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 COVID-19 RAPID ANTIGEN MARKET PRODUCTION BY REGION
9.1 Global Production of Covid-19 Rapid Antigen by Region(2020-2025)
9.2 Global Covid-19 Rapid Antigen Revenue Market Share by Region (2020-2025)
9.3 Global Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Covid-19 Rapid Antigen Production
9.4.1 North America Covid-19 Rapid Antigen Production Growth Rate (2020-2025)
9.4.2 North America Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Covid-19 Rapid Antigen Production
9.5.1 Europe Covid-19 Rapid Antigen Production Growth Rate (2020-2025)
9.5.2 Europe Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Covid-19 Rapid Antigen Production (2020-2025)
9.6.1 Japan Covid-19 Rapid Antigen Production Growth Rate (2020-2025)
9.6.2 Japan Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Covid-19 Rapid Antigen Production (2020-2025)
9.7.1 China Covid-19 Rapid Antigen Production Growth Rate (2020-2025)
9.7.2 China Covid-19 Rapid Antigen Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Covid-19 Rapid Antigen Product Overview
10.1.3 Abbott Covid-19 Rapid Antigen Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Access Bio
10.2.1 Access Bio Basic Information
10.2.2 Access Bio Covid-19 Rapid Antigen Product Overview
10.2.3 Access Bio Covid-19 Rapid Antigen Product Market Performance
10.2.4 Access Bio Business Overview
10.2.5 Access Bio SWOT Analysis
10.2.6 Access Bio Recent Developments
10.3 BD
10.3.1 BD Basic Information
10.3.2 BD Covid-19 Rapid Antigen Product Overview
10.3.3 BD Covid-19 Rapid Antigen Product Market Performance
10.3.4 BD Business Overview
10.3.5 BD SWOT Analysis
10.3.6 BD Recent Developments
10.4 Quidel
10.4.1 Quidel Basic Information
10.4.2 Quidel Covid-19 Rapid Antigen Product Overview
10.4.3 Quidel Covid-19 Rapid Antigen Product Market Performance
10.4.4 Quidel Business Overview
10.4.5 Quidel Recent Developments
10.5 Fujirebio
10.5.1 Fujirebio Basic Information
10.5.2 Fujirebio Covid-19 Rapid Antigen Product Overview
10.5.3 Fujirebio Covid-19 Rapid Antigen Product Market Performance
10.5.4 Fujirebio Business Overview
10.5.5 Fujirebio Recent Developments
10.6 Ellume
10.6.1 Ellume Basic Information
10.6.2 Ellume Covid-19 Rapid Antigen Product Overview
10.6.3 Ellume Covid-19 Rapid Antigen Product Market Performance
10.6.4 Ellume Business Overview
10.6.5 Ellume Recent Developments
10.7 OraSure Technologies
10.7.1 OraSure Technologies Basic Information
10.7.2 OraSure Technologies Covid-19 Rapid Antigen Product Overview
10.7.3 OraSure Technologies Covid-19 Rapid Antigen Product Market Performance
10.7.4 OraSure Technologies Business Overview
10.7.5 OraSure Technologies Recent Developments
10.8 Clip Health
10.8.1 Clip Health Basic Information
10.8.2 Clip Health Covid-19 Rapid Antigen Product Overview
10.8.3 Clip Health Covid-19 Rapid Antigen Product Market Performance
10.8.4 Clip Health Business Overview
10.8.5 Clip Health Recent Developments
10.9 Celltrion Healthcare
10.9.1 Celltrion Healthcare Basic Information
10.9.2 Celltrion Healthcare Covid-19 Rapid Antigen Product Overview
10.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Product Market Performance
10.9.4 Celltrion Healthcare Business Overview
10.9.5 Celltrion Healthcare Recent Developments
10.10 Salofa Oy
10.10.1 Salofa Oy Basic Information
10.10.2 Salofa Oy Covid-19 Rapid Antigen Product Overview
10.10.3 Salofa Oy Covid-19 Rapid Antigen Product Market Performance
10.10.4 Salofa Oy Business Overview
10.10.5 Salofa Oy Recent Developments
10.11 iHealth Labs
10.11.1 iHealth Labs Basic Information
10.11.2 iHealth Labs Covid-19 Rapid Antigen Product Overview
10.11.3 iHealth Labs Covid-19 Rapid Antigen Product Market Performance
10.11.4 iHealth Labs Business Overview
10.11.5 iHealth Labs Recent Developments
10.12 Novegent
10.12.1 Novegent Basic Information
10.12.2 Novegent Covid-19 Rapid Antigen Product Overview
10.12.3 Novegent Covid-19 Rapid Antigen Product Market Performance
10.12.4 Novegent Business Overview
10.12.5 Novegent Recent Developments
10.13 Hangzhou Alltest Biotech
10.13.1 Hangzhou Alltest Biotech Basic Information
10.13.2 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Overview
10.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Market Performance
10.13.4 Hangzhou Alltest Biotech Business Overview
10.13.5 Hangzhou Alltest Biotech Recent Developments
10.14 Guangzhou Decheng Biotechnology
10.14.1 Guangzhou Decheng Biotechnology Basic Information
10.14.2 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Overview
10.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Market Performance
10.14.4 Guangzhou Decheng Biotechnology Business Overview
10.14.5 Guangzhou Decheng Biotechnology Recent Developments
10.15 SD Biosensor
10.15.1 SD Biosensor Basic Information
10.15.2 SD Biosensor Covid-19 Rapid Antigen Product Overview
10.15.3 SD Biosensor Covid-19 Rapid Antigen Product Market Performance
10.15.4 SD Biosensor Business Overview
10.15.5 SD Biosensor Recent Developments
10.16 MP Biomedical
10.16.1 MP Biomedical Basic Information
10.16.2 MP Biomedical Covid-19 Rapid Antigen Product Overview
10.16.3 MP Biomedical Covid-19 Rapid Antigen Product Market Performance
10.16.4 MP Biomedical Business Overview
10.16.5 MP Biomedical Recent Developments
10.17 Jiangsu Well Biotech
10.17.1 Jiangsu Well Biotech Basic Information
10.17.2 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Overview
10.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Market Performance
10.17.4 Jiangsu Well Biotech Business Overview
10.17.5 Jiangsu Well Biotech Recent Developments
10.18 CTK Biotech
10.18.1 CTK Biotech Basic Information
10.18.2 CTK Biotech Covid-19 Rapid Antigen Product Overview
10.18.3 CTK Biotech Covid-19 Rapid Antigen Product Market Performance
10.18.4 CTK Biotech Business Overview
10.18.5 CTK Biotech Recent Developments
10.19 Hangzhou Laihe Biotech
10.19.1 Hangzhou Laihe Biotech Basic Information
10.19.2 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Overview
10.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Market Performance
10.19.4 Hangzhou Laihe Biotech Business Overview
10.19.5 Hangzhou Laihe Biotech Recent Developments
10.20 Innovation Scientific
10.20.1 Innovation Scientific Basic Information
10.20.2 Innovation Scientific Covid-19 Rapid Antigen Product Overview
10.20.3 Innovation Scientific Covid-19 Rapid Antigen Product Market Performance
10.20.4 Innovation Scientific Business Overview
10.20.5 Innovation Scientific Recent Developments
10.21 Biohit Healthcare
10.21.1 Biohit Healthcare Basic Information
10.21.2 Biohit Healthcare Covid-19 Rapid Antigen Product Overview
10.21.3 Biohit Healthcare Covid-19 Rapid Antigen Product Market Performance
10.21.4 Biohit Healthcare Business Overview
10.21.5 Biohit Healthcare Recent Developments
10.22 ACON Biotech
10.22.1 ACON Biotech Basic Information
10.22.2 ACON Biotech Covid-19 Rapid Antigen Product Overview
10.22.3 ACON Biotech Covid-19 Rapid Antigen Product Market Performance
10.22.4 ACON Biotech Business Overview
10.22.5 ACON Biotech Recent Developments
10.23 Assure Tech
10.23.1 Assure Tech Basic Information
10.23.2 Assure Tech Covid-19 Rapid Antigen Product Overview
10.23.3 Assure Tech Covid-19 Rapid Antigen Product Market Performance
10.23.4 Assure Tech Business Overview
10.23.5 Assure Tech Recent Developments
10.24 Hangzhou Clongene Biotech
10.24.1 Hangzhou Clongene Biotech Basic Information
10.24.2 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Overview
10.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Market Performance
10.24.4 Hangzhou Clongene Biotech Business Overview
10.24.5 Hangzhou Clongene Biotech Recent Developments
10.25 Hangzhou Testsea Biotechnology
10.25.1 Hangzhou Testsea Biotechnology Basic Information
10.25.2 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Overview
10.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Market Performance
10.25.4 Hangzhou Testsea Biotechnology Business Overview
10.25.5 Hangzhou Testsea Biotechnology Recent Developments
11 COVID-19 RAPID ANTIGEN MARKET FORECAST BY REGION
11.1 Global Covid-19 Rapid Antigen Market Size Forecast
11.2 Global Covid-19 Rapid Antigen Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Covid-19 Rapid Antigen Market Size Forecast by Country
11.2.3 Asia Pacific Covid-19 Rapid Antigen Market Size Forecast by Region
11.2.4 South America Covid-19 Rapid Antigen Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Covid-19 Rapid Antigen by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Covid-19 Rapid Antigen Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Covid-19 Rapid Antigen by Type (2026-2035)
12.1.2 Global Covid-19 Rapid Antigen Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Covid-19 Rapid Antigen by Type (2026-2035)
12.2 Global Covid-19 Rapid Antigen Market Forecast by Application (2026-2035)
12.2.1 Global Covid-19 Rapid Antigen Sales (K Units) Forecast by Application
12.2.2 Global Covid-19 Rapid Antigen Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Covid-19 Rapid Antigen Market Size by Type (M USD)
Table 4. Global Covid-19 Rapid Antigen Market Size by Application
Table 5. Covid-19 Rapid Antigen Market Size Comparison by Region (M USD)
Table 6. Global Covid-19 Rapid Antigen Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Covid-19 Rapid Antigen Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Antigen as of 2025)
Table 11. Global Market Covid-19 Rapid Antigen Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Covid-19 Rapid Antigen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Covid-19 Rapid Antigen Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Covid-19 Rapid Antigen Sales by Type (K Units)
Table 27. Global Covid-19 Rapid Antigen Market Size by Type (M USD)
Table 28. Global Covid-19 Rapid Antigen Sales (K Units) by Type (2020-2025)
Table 29. Global Covid-19 Rapid Antigen Sales Market Share by Type (2020-2025)
Table 30. Global Covid-19 Rapid Antigen Market Size (M USD) by Type (2020-2025)
Table 31. Global Covid-19 Rapid Antigen Market Share by Type (2020-2025)
Table 32. Global Covid-19 Rapid Antigen Price (USD/Unit) by Type (2020-2025)
Table 33. Global Covid-19 Rapid Antigen Sales (K Units) by Application
Table 34. Global Covid-19 Rapid Antigen Market Size by Application
Table 35. Global Covid-19 Rapid Antigen Sales by Application (2020-2025) & (K Units)
Table 36. Global Covid-19 Rapid Antigen Sales Market Share by Application (2020-2025)
Table 37. Global Covid-19 Rapid Antigen Market Size by Application (2020-2025) & (M USD)
Table 38. Global Covid-19 Rapid Antigen Market Share by Application (2020-2025)
Table 39. Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2020-2025)
Table 40. Global Covid-19 Rapid Antigen Sales by Region (2020-2025) & (K Units)
Table 41. Global Covid-19 Rapid Antigen Sales Market Share by Region (2020-2025)
Table 42. Global Covid-19 Rapid Antigen Market Size by Region (2020-2025) & (M USD)
Table 43. Global Covid-19 Rapid Antigen Market Size by Region (2020-2025)
Table 44. North America Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
Table 45. North America Covid-19 Rapid Antigen Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
Table 47. Europe Covid-19 Rapid Antigen Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Covid-19 Rapid Antigen Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Covid-19 Rapid Antigen Market Size by Region (2020-2025) & (M USD)
Table 50. South America Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
Table 51. South America Covid-19 Rapid Antigen Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Covid-19 Rapid Antigen Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Covid-19 Rapid Antigen Market Size by Region (2020-2025) & (M USD)
Table 54. Global Covid-19 Rapid Antigen Production (K Units) by Region(2020-2025)
Table 55. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Covid-19 Rapid Antigen Revenue Market Share by Region (2020-2025)
Table 57. Global Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott Covid-19 Rapid Antigen Product Overview
Table 64. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Access Bio Basic Information
Table 69. Access Bio Covid-19 Rapid Antigen Product Overview
Table 70. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Access Bio Business Overview
Table 72. Access Bio SWOT Analysis
Table 73. Access Bio Recent Developments
Table 74. BD Basic Information
Table 75. BD Covid-19 Rapid Antigen Product Overview
Table 76. BD Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. BD Business Overview
Table 78. BD SWOT Analysis
Table 79. BD Recent Developments
Table 80. Quidel Basic Information
Table 81. Quidel Covid-19 Rapid Antigen Product Overview
Table 82. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Quidel Business Overview
Table 84. Quidel Recent Developments
Table 85. Fujirebio Basic Information
Table 86. Fujirebio Covid-19 Rapid Antigen Product Overview
Table 87. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Fujirebio Business Overview
Table 89. Fujirebio Recent Developments
Table 90. Ellume Basic Information
Table 91. Ellume Covid-19 Rapid Antigen Product Overview
Table 92. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Ellume Business Overview
Table 94. Ellume Recent Developments
Table 95. OraSure Technologies Basic Information
Table 96. OraSure Technologies Covid-19 Rapid Antigen Product Overview
Table 97. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. OraSure Technologies Business Overview
Table 99. OraSure Technologies Recent Developments
Table 100. Clip Health Basic Information
Table 101. Clip Health Covid-19 Rapid Antigen Product Overview
Table 102. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Clip Health Business Overview
Table 104. Clip Health Recent Developments
Table 105. Celltrion Healthcare Basic Information
Table 106. Celltrion Healthcare Covid-19 Rapid Antigen Product Overview
Table 107. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Celltrion Healthcare Business Overview
Table 109. Celltrion Healthcare Recent Developments
Table 110. Salofa Oy Basic Information
Table 111. Salofa Oy Covid-19 Rapid Antigen Product Overview
Table 112. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Salofa Oy Business Overview
Table 114. Salofa Oy Recent Developments
Table 115. iHealth Labs Basic Information
Table 116. iHealth Labs Covid-19 Rapid Antigen Product Overview
Table 117. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. iHealth Labs Business Overview
Table 119. iHealth Labs Recent Developments
Table 120. Novegent Basic Information
Table 121. Novegent Covid-19 Rapid Antigen Product Overview
Table 122. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Novegent Business Overview
Table 124. Novegent Recent Developments
Table 125. Hangzhou Alltest Biotech Basic Information
Table 126. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Overview
Table 127. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Hangzhou Alltest Biotech Business Overview
Table 129. Hangzhou Alltest Biotech Recent Developments
Table 130. Guangzhou Decheng Biotechnology Basic Information
Table 131. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Overview
Table 132. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Guangzhou Decheng Biotechnology Business Overview
Table 134. Guangzhou Decheng Biotechnology Recent Developments
Table 135. SD Biosensor Basic Information
Table 136. SD Biosensor Covid-19 Rapid Antigen Product Overview
Table 137. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. SD Biosensor Business Overview
Table 139. SD Biosensor Recent Developments
Table 140. MP Biomedical Basic Information
Table 141. MP Biomedical Covid-19 Rapid Antigen Product Overview
Table 142. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. MP Biomedical Business Overview
Table 144. MP Biomedical Recent Developments
Table 145. Jiangsu Well Biotech Basic Information
Table 146. Jiangsu Well Biotech Covid-19 Rapid Antigen Product Overview
Table 147. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Jiangsu Well Biotech Business Overview
Table 149. Jiangsu Well Biotech Recent Developments
Table 150. CTK Biotech Basic Information
Table 151. CTK Biotech Covid-19 Rapid Antigen Product Overview
Table 152. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. CTK Biotech Business Overview
Table 154. CTK Biotech Recent Developments
Table 155. Hangzhou Laihe Biotech Basic Information
Table 156. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Overview
Table 157. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Hangzhou Laihe Biotech Business Overview
Table 159. Hangzhou Laihe Biotech Recent Developments
Table 160. Innovation Scientific Basic Information
Table 161. Innovation Scientific Covid-19 Rapid Antigen Product Overview
Table 162. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Innovation Scientific Business Overview
Table 164. Innovation Scientific Recent Developments
Table 165. Biohit Healthcare Basic Information
Table 166. Biohit Healthcare Covid-19 Rapid Antigen Product Overview
Table 167. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Biohit Healthcare Business Overview
Table 169. Biohit Healthcare Recent Developments
Table 170. ACON Biotech Basic Information
Table 171. ACON Biotech Covid-19 Rapid Antigen Product Overview
Table 172. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. ACON Biotech Business Overview
Table 174. ACON Biotech Recent Developments
Table 175. Assure Tech Basic Information
Table 176. Assure Tech Covid-19 Rapid Antigen Product Overview
Table 177. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Assure Tech Business Overview
Table 179. Assure Tech Recent Developments
Table 180. Hangzhou Clongene Biotech Basic Information
Table 181. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Overview
Table 182. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Hangzhou Clongene Biotech Business Overview
Table 184. Hangzhou Clongene Biotech Recent Developments
Table 185. Hangzhou Testsea Biotechnology Basic Information
Table 186. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Overview
Table 187. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Hangzhou Testsea Biotechnology Business Overview
Table 189. Hangzhou Testsea Biotechnology Recent Developments
Table 190. Global Covid-19 Rapid Antigen Sales Forecast by Region (2026-2035) & (K Units)
Table 191. Global Covid-19 Rapid Antigen Market Size Forecast by Region (2026-2035) & (M USD)
Table 192. North America Covid-19 Rapid Antigen Sales Forecast by Country (2026-2035) & (K Units)
Table 193. North America Covid-19 Rapid Antigen Market Size Forecast by Country (2026-2035) & (M USD)
Table 194. Europe Covid-19 Rapid Antigen Sales Forecast by Country (2026-2035) & (K Units)
Table 195. Europe Covid-19 Rapid Antigen Market Size Forecast by Country (2026-2035) & (M USD)
Table 196. Asia Pacific Covid-19 Rapid Antigen Sales Forecast by Region (2026-2035) & (K Units)
Table 197. Asia Pacific Covid-19 Rapid Antigen Market Size Forecast by Region (2026-2035) & (M USD)
Table 198. South America Covid-19 Rapid Antigen Sales Forecast by Country (2026-2035) & (K Units)
Table 199. South America Covid-19 Rapid Antigen Market Size Forecast by Country (2026-2035) & (M USD)
Table 200. Middle East and Africa Covid-19 Rapid Antigen Sales Forecast by Country (2026-2035) & (Units)
Table 201. Middle East and Africa Covid-19 Rapid Antigen Market Size Forecast by Country (2026-2035) & (M USD)
Table 202. Global Covid-19 Rapid Antigen Sales Forecast by Type (2026-2035) & (K Units)
Table 203. Global Covid-19 Rapid Antigen Market Size Forecast by Type (2026-2035) & (M USD)
Table 204. Global Covid-19 Rapid Antigen Price Forecast by Type (2026-2035) & (USD/Unit)
Table 205. Global Covid-19 Rapid Antigen Sales (K Units) Forecast by Application (2026-2035)
Table 206. Global Covid-19 Rapid Antigen Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Covid-19 Rapid Antigen Market Size by Type (M USD)
Table 4. Global Covid-19 Rapid Antigen Market Size by Application
Table 5. Covid-19 Rapid Antigen Market Size Comparison by Region (M USD)
Table 6. Global Covid-19 Rapid Antigen Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Covid-19 Rapid Antigen Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Antigen as of 2025)
Table 11. Global Market Covid-19 Rapid Antigen Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Covid-19 Rapid Antigen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Covid-19 Rapid Antigen Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Covid-19 Rapid Antigen Sales by Type (K Units)
Table 27. Global Covid-19 Rapid Antigen Market Size by Type (M USD)
Table 28. Global Covid-19 Rapid Antigen Sales (K Units) by Type (2020-2025)
Table 29. Global Covid-19 Rapid Antigen Sales Market Share by Type (2020-2025)
Table 30. Global Covid-19 Rapid Antigen Market Size (M USD) by Type (2020-2025)
Table 31. Global Covid-19 Rapid Antigen Market Share by Type (2020-2025)
Table 32. Global Covid-19 Rapid Antigen Price (USD/Unit) by Type (2020-2025)
Table 33. Global Covid-19 Rapid Antigen Sales (K Units) by Application
Table 34. Global Covid-19 Rapid Antigen Market Size by Application
Table 35. Global Covid-19 Rapid Antigen Sales by Application (2020-2025) & (K Units)
Table 36. Global Covid-19 Rapid Antigen Sales Market Share by Application (2020-2025)
Table 37. Global Covid-19 Rapid Antigen Market Size by Application (2020-2025) & (M USD)
Table 38. Global Covid-19 Rapid Antigen Market Share by Application (2020-2025)
Table 39. Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2020-2025)
Table 40. Global Covid-19 Rapid Antigen Sales by Region (2020-2025) & (K Units)
Table 41. Global Covid-19 Rapid Antigen Sales Market Share by Region (2020-2025)
Table 42. Global Covid-19 Rapid Antigen Market Size by Region (2020-2025) & (M USD)
Table 43. Global Covid-19 Rapid Antigen Market Size by Region (2020-2025)
Table 44. North America Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
Table 45. North America Covid-19 Rapid Antigen Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
Table 47. Europe Covid-19 Rapid Antigen Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Covid-19 Rapid Antigen Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Covid-19 Rapid Antigen Market Size by Region (2020-2025) & (M USD)
Table 50. South America Covid-19 Rapid Antigen Sales by Country (2020-2025) & (K Units)
Table 51. South America Covid-19 Rapid Antigen Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Covid-19 Rapid Antigen Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Covid-19 Rapid Antigen Market Size by Region (2020-2025) & (M USD)
Table 54. Global Covid-19 Rapid Antigen Production (K Units) by Region(2020-2025)
Table 55. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Covid-19 Rapid Antigen Revenue Market Share by Region (2020-2025)
Table 57. Global Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Covid-19 Rapid Antigen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott Covid-19 Rapid Antigen Product Overview
Table 64. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Access Bio Basic Information
Table 69. Access Bio Covid-19 Rapid Antigen Product Overview
Table 70. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Access Bio Business Overview
Table 72. Access Bio SWOT Analysis
Table 73. Access Bio Recent Developments
Table 74. BD Basic Information
Table 75. BD Covid-19 Rapid Antigen Product Overview
Table 76. BD Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. BD Business Overview
Table 78. BD SWOT Analysis
Table 79. BD Recent Developments
Table 80. Quidel Basic Information
Table 81. Quidel Covid-19 Rapid Antigen Product Overview
Table 82. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Quidel Business Overview
Table 84. Quidel Recent Developments
Table 85. Fujirebio Basic Information
Table 86. Fujirebio Covid-19 Rapid Antigen Product Overview
Table 87. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Fujirebio Business Overview
Table 89. Fujirebio Recent Developments
Table 90. Ellume Basic Information
Table 91. Ellume Covid-19 Rapid Antigen Product Overview
Table 92. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Ellume Business Overview
Table 94. Ellume Recent Developments
Table 95. OraSure Technologies Basic Information
Table 96. OraSure Technologies Covid-19 Rapid Antigen Product Overview
Table 97. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. OraSure Technologies Business Overview
Table 99. OraSure Technologies Recent Developments
Table 100. Clip Health Basic Information
Table 101. Clip Health Covid-19 Rapid Antigen Product Overview
Table 102. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Clip Health Business Overview
Table 104. Clip Health Recent Developments
Table 105. Celltrion Healthcare Basic Information
Table 106. Celltrion Healthcare Covid-19 Rapid Antigen Product Overview
Table 107. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Celltrion Healthcare Business Overview
Table 109. Celltrion Healthcare Recent Developments
Table 110. Salofa Oy Basic Information
Table 111. Salofa Oy Covid-19 Rapid Antigen Product Overview
Table 112. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Salofa Oy Business Overview
Table 114. Salofa Oy Recent Developments
Table 115. iHealth Labs Basic Information
Table 116. iHealth Labs Covid-19 Rapid Antigen Product Overview
Table 117. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. iHealth Labs Business Overview
Table 119. iHealth Labs Recent Developments
Table 120. Novegent Basic Information
Table 121. Novegent Covid-19 Rapid Antigen Product Overview
Table 122. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Novegent Business Overview
Table 124. Novegent Recent Developments
Table 125. Hangzhou Alltest Biotech Basic Information
Table 126. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Overview
Table 127. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Hangzhou Alltest Biotech Business Overview
Table 129. Hangzhou Alltest Biotech Recent Developments
Table 130. Guangzhou Decheng Biotechnology Basic Information
Table 131. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Overview
Table 132. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Guangzhou Decheng Biotechnology Business Overview
Table 134. Guangzhou Decheng Biotechnology Recent Developments
Table 135. SD Biosensor Basic Information
Table 136. SD Biosensor Covid-19 Rapid Antigen Product Overview
Table 137. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. SD Biosensor Business Overview
Table 139. SD Biosensor Recent Developments
Table 140. MP Biomedical Basic Information
Table 141. MP Biomedical Covid-19 Rapid Antigen Product Overview
Table 142. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. MP Biomedical Business Overview
Table 144. MP Biomedical Recent Developments
Table 145. Jiangsu Well Biotech Basic Information
Table 146. Jiangsu Well Biotech Covid-19 Rapid Antigen Product Overview
Table 147. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Jiangsu Well Biotech Business Overview
Table 149. Jiangsu Well Biotech Recent Developments
Table 150. CTK Biotech Basic Information
Table 151. CTK Biotech Covid-19 Rapid Antigen Product Overview
Table 152. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. CTK Biotech Business Overview
Table 154. CTK Biotech Recent Developments
Table 155. Hangzhou Laihe Biotech Basic Information
Table 156. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Overview
Table 157. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Hangzhou Laihe Biotech Business Overview
Table 159. Hangzhou Laihe Biotech Recent Developments
Table 160. Innovation Scientific Basic Information
Table 161. Innovation Scientific Covid-19 Rapid Antigen Product Overview
Table 162. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Innovation Scientific Business Overview
Table 164. Innovation Scientific Recent Developments
Table 165. Biohit Healthcare Basic Information
Table 166. Biohit Healthcare Covid-19 Rapid Antigen Product Overview
Table 167. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Biohit Healthcare Business Overview
Table 169. Biohit Healthcare Recent Developments
Table 170. ACON Biotech Basic Information
Table 171. ACON Biotech Covid-19 Rapid Antigen Product Overview
Table 172. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. ACON Biotech Business Overview
Table 174. ACON Biotech Recent Developments
Table 175. Assure Tech Basic Information
Table 176. Assure Tech Covid-19 Rapid Antigen Product Overview
Table 177. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Assure Tech Business Overview
Table 179. Assure Tech Recent Developments
Table 180. Hangzhou Clongene Biotech Basic Information
Table 181. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Overview
Table 182. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Hangzhou Clongene Biotech Business Overview
Table 184. Hangzhou Clongene Biotech Recent Developments
Table 185. Hangzhou Testsea Biotechnology Basic Information
Table 186. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Overview
Table 187. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Hangzhou Testsea Biotechnology Business Overview
Table 189. Hangzhou Testsea Biotechnology Recent Developments
Table 190. Global Covid-19 Rapid Antigen Sales Forecast by Region (2026-2035) & (K Units)
Table 191. Global Covid-19 Rapid Antigen Market Size Forecast by Region (2026-2035) & (M USD)
Table 192. North America Covid-19 Rapid Antigen Sales Forecast by Country (2026-2035) & (K Units)
Table 193. North America Covid-19 Rapid Antigen Market Size Forecast by Country (2026-2035) & (M USD)
Table 194. Europe Covid-19 Rapid Antigen Sales Forecast by Country (2026-2035) & (K Units)
Table 195. Europe Covid-19 Rapid Antigen Market Size Forecast by Country (2026-2035) & (M USD)
Table 196. Asia Pacific Covid-19 Rapid Antigen Sales Forecast by Region (2026-2035) & (K Units)
Table 197. Asia Pacific Covid-19 Rapid Antigen Market Size Forecast by Region (2026-2035) & (M USD)
Table 198. South America Covid-19 Rapid Antigen Sales Forecast by Country (2026-2035) & (K Units)
Table 199. South America Covid-19 Rapid Antigen Market Size Forecast by Country (2026-2035) & (M USD)
Table 200. Middle East and Africa Covid-19 Rapid Antigen Sales Forecast by Country (2026-2035) & (Units)
Table 201. Middle East and Africa Covid-19 Rapid Antigen Market Size Forecast by Country (2026-2035) & (M USD)
Table 202. Global Covid-19 Rapid Antigen Sales Forecast by Type (2026-2035) & (K Units)
Table 203. Global Covid-19 Rapid Antigen Market Size Forecast by Type (2026-2035) & (M USD)
Table 204. Global Covid-19 Rapid Antigen Price Forecast by Type (2026-2035) & (USD/Unit)
Table 205. Global Covid-19 Rapid Antigen Sales (K Units) Forecast by Application (2026-2035)
Table 206. Global Covid-19 Rapid Antigen Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Covid-19 Rapid Antigen
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Covid-19 Rapid Antigen Market Size (M USD), 2025-2035
Figure 5. Global Covid-19 Rapid Antigen Market Size (M USD) (2020-2035)
Figure 6. Global Covid-19 Rapid Antigen Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Covid-19 Rapid Antigen Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Covid-19 Rapid Antigen Product Life Cycle
Figure 13. Covid-19 Rapid Antigen Sales Share by Manufacturers in 2025
Figure 14. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers in 2025
Figure 15. Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Covid-19 Rapid Antigen Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Covid-19 Rapid Antigen Revenue in 2025
Figure 18. Industry Chain Map of Covid-19 Rapid Antigen
Figure 19. Global Covid-19 Rapid Antigen Market PEST Analysis
Figure 20. Global Covid-19 Rapid Antigen Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Covid-19 Rapid Antigen Market Share by Type
Figure 27. Sales Market Share of Covid-19 Rapid Antigen by Type (2020-2025)
Figure 28. Sales Market Share of Covid-19 Rapid Antigen by Type in 2025
Figure 29. Market Share of Covid-19 Rapid Antigen by Type (2020-2025)
Figure 30. Market Share of Covid-19 Rapid Antigen by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Covid-19 Rapid Antigen Market Share by Application
Figure 33. Global Covid-19 Rapid Antigen Sales Market Share by Application (2020-2025)
Figure 34. Global Covid-19 Rapid Antigen Sales Market Share by Application in 2025
Figure 35. Global Covid-19 Rapid Antigen Market Share by Application (2020-2025)
Figure 36. Global Covid-19 Rapid Antigen Market Share by Application in 2025
Figure 37. Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2020-2025)
Figure 38. Global Covid-19 Rapid Antigen Sales Market Share by Region (2020-2025)
Figure 39. Global Covid-19 Rapid Antigen Market Size by Region (2020-2025)
Figure 40. North America Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Covid-19 Rapid Antigen Sales Market Share by Country in 2024
Figure 43. North America Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Covid-19 Rapid Antigen Market Size by Country in 2024
Figure 45. U.S. Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Covid-19 Rapid Antigen Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Covid-19 Rapid Antigen Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Covid-19 Rapid Antigen Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Covid-19 Rapid Antigen Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Covid-19 Rapid Antigen Sales Market Share by Country in 2024
Figure 53. Europe Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Covid-19 Rapid Antigen Market Size by Country in 2024
Figure 55. Germany Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Covid-19 Rapid Antigen Sales Market Share by Region in 2024
Figure 67. Asia Pacific Covid-19 Rapid Antigen Market Size by Region in 2024
Figure 68. China Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 79. South America Covid-19 Rapid Antigen Sales Market Share by Country in 2024
Figure 80. South America Covid-19 Rapid Antigen Market Size and Growth Rate (M USD)
Figure 81. South America Covid-19 Rapid Antigen Market Size by Country in 2024
Figure 82. Brazil Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Covid-19 Rapid Antigen Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Covid-19 Rapid Antigen Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Covid-19 Rapid Antigen Market Size by Region in 2024
Figure 92. Saudi Arabia Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Covid-19 Rapid Antigen Production Market Share by Region (2020-2025)
Figure 103. North America Covid-19 Rapid Antigen Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Covid-19 Rapid Antigen Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Covid-19 Rapid Antigen Production (K Units) Growth Rate (2020-2025)
Figure 106. China Covid-19 Rapid Antigen Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Covid-19 Rapid Antigen Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Covid-19 Rapid Antigen Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Covid-19 Rapid Antigen Market Share Forecast by Type (2026-2035)
Figure 111. Global Covid-19 Rapid Antigen Sales Forecast by Application (2026-2035)
Figure 112. Global Covid-19 Rapid Antigen Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Covid-19 Rapid Antigen
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Covid-19 Rapid Antigen Market Size (M USD), 2025-2035
Figure 5. Global Covid-19 Rapid Antigen Market Size (M USD) (2020-2035)
Figure 6. Global Covid-19 Rapid Antigen Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Covid-19 Rapid Antigen Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Covid-19 Rapid Antigen Product Life Cycle
Figure 13. Covid-19 Rapid Antigen Sales Share by Manufacturers in 2025
Figure 14. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers in 2025
Figure 15. Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Covid-19 Rapid Antigen Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Covid-19 Rapid Antigen Revenue in 2025
Figure 18. Industry Chain Map of Covid-19 Rapid Antigen
Figure 19. Global Covid-19 Rapid Antigen Market PEST Analysis
Figure 20. Global Covid-19 Rapid Antigen Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Covid-19 Rapid Antigen Market Share by Type
Figure 27. Sales Market Share of Covid-19 Rapid Antigen by Type (2020-2025)
Figure 28. Sales Market Share of Covid-19 Rapid Antigen by Type in 2025
Figure 29. Market Share of Covid-19 Rapid Antigen by Type (2020-2025)
Figure 30. Market Share of Covid-19 Rapid Antigen by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Covid-19 Rapid Antigen Market Share by Application
Figure 33. Global Covid-19 Rapid Antigen Sales Market Share by Application (2020-2025)
Figure 34. Global Covid-19 Rapid Antigen Sales Market Share by Application in 2025
Figure 35. Global Covid-19 Rapid Antigen Market Share by Application (2020-2025)
Figure 36. Global Covid-19 Rapid Antigen Market Share by Application in 2025
Figure 37. Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2020-2025)
Figure 38. Global Covid-19 Rapid Antigen Sales Market Share by Region (2020-2025)
Figure 39. Global Covid-19 Rapid Antigen Market Size by Region (2020-2025)
Figure 40. North America Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Covid-19 Rapid Antigen Sales Market Share by Country in 2024
Figure 43. North America Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Covid-19 Rapid Antigen Market Size by Country in 2024
Figure 45. U.S. Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Covid-19 Rapid Antigen Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Covid-19 Rapid Antigen Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Covid-19 Rapid Antigen Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Covid-19 Rapid Antigen Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Covid-19 Rapid Antigen Sales Market Share by Country in 2024
Figure 53. Europe Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Covid-19 Rapid Antigen Market Size by Country in 2024
Figure 55. Germany Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Covid-19 Rapid Antigen Sales Market Share by Region in 2024
Figure 67. Asia Pacific Covid-19 Rapid Antigen Market Size by Region in 2024
Figure 68. China Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 79. South America Covid-19 Rapid Antigen Sales Market Share by Country in 2024
Figure 80. South America Covid-19 Rapid Antigen Market Size and Growth Rate (M USD)
Figure 81. South America Covid-19 Rapid Antigen Market Size by Country in 2024
Figure 82. Brazil Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Covid-19 Rapid Antigen Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Covid-19 Rapid Antigen Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Covid-19 Rapid Antigen Market Size by Region in 2024
Figure 92. Saudi Arabia Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Covid-19 Rapid Antigen Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Covid-19 Rapid Antigen Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Covid-19 Rapid Antigen Production Market Share by Region (2020-2025)
Figure 103. North America Covid-19 Rapid Antigen Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Covid-19 Rapid Antigen Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Covid-19 Rapid Antigen Production (K Units) Growth Rate (2020-2025)
Figure 106. China Covid-19 Rapid Antigen Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Covid-19 Rapid Antigen Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Covid-19 Rapid Antigen Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Covid-19 Rapid Antigen Market Share Forecast by Type (2026-2035)
Figure 111. Global Covid-19 Rapid Antigen Sales Forecast by Application (2026-2035)
Figure 112. Global Covid-19 Rapid Antigen Market Share Forecast by Application (2026-2035)
More Publications
Global Wrist Immobilizer Surgical Kit Market Research Report 2025(Status and Outlook)
US$ 2,800.00
January 2025
163 pages
Global Denture Adhesive Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
142 pages
Global Castleman Disease Treatment Market Research Report 2025(Status and Outlook)
US$ 3,200.00
September 2025
137 pages
Global Nasopharyngeal Carcinoma Treatment Market Research Report 2026(Status and Outlook)
US$ 2,980.00
March 2026
146 pages
Global Sterile Water for Inhalation Market Research Report 2025(Status and Outlook)
US$ 3,200.00
February 2025
224 pages
